Frank D. Lee Pacira Bio Sciences, Inc. (PCRX) insider trading activity

PCRX Quotes by TradingView

Frank D. Lee is Chief Executive Officer of Pacira BioSciences, Inc.. Currently has a direct ownership of 98,409 shares of PCRX, which is worth approximately $2.2 Million. The most recent transaction as insider was on Jan 02, 2025, when has been sold 9,375 shares (Common Stock) at a price of $18.33 per share, resulting in proceeds of $171,843. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 98.4K
8.7% 3M change
1.12% 12M change
Total Value Held $2.2 Million

Frank D. Lee Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 02 2025
SELL
Payment of exercise price or tax liability
$171,843 $18.33 p/Share
9,375 Reduced 8.7%
98,409 Common Stock
Aug 12 2024
BUY
Open market or private purchase
$99,994 $12.1 p/Share
8,264 Added 7.12%
107,784 Common Stock
Jan 02 2024
BUY
Grant, award, or other acquisition
-
99,520 Added 50.0%
99,520 Common Stock

Also insider at

BHC
Bausch Health Companies Inc. Healthcare
Director
FMTX
Forma Therapeutics Holdings, Inc. Healthcare
President and CEO
BOLT
Bolt Biotherapeutics, Inc. Healthcare
FDL

Frank D. Lee

Chief Executive Officer
Watertown, MA

Track Institutional and Insider Activities on PCRX

Follow Pacira BioSciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PCRX shares.

Notify only if

Insider Trading

Get notified when an Pacira Bio Sciences, Inc. insider buys or sells PCRX shares.

Notify only if

News

Receive news related to Pacira BioSciences, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PCRX